The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover


Eye on China


Conferences ListingConferences

Pharma Sales
A blueprint for changing diabetes in Indonesia
Among the 242 million people living in Indonesia, 7.6 million have diabetes but less than 1% is achieving recommended treatment targets. In its fifth Blueprint for Change business case published, Novo Nordisk examines four barriers that prevent quality and accessibility of diabetes care and identifies the opportunities to address them.

“If action is not taken, demand for healthcare will outstrip Indonesia’s ability to provide it,” says Charlotte Ersbøll, corporate vice president, Global Stakeholder Engagement, Novo Nordisk. “In the end, it will be people with diabetes and their families that will carry the highest cost.”

The Indonesia Blueprint for Change recommends investments in diabetes awareness, increasing the supply of healthcare professionals specializing in diabetes care and improving diabetes education among internists and general practitioners. Concrete action suggested is the need to involve more levels of healthcare professionals, including nurses and diabetes educators. A final conclusion from the case is the need to make these investments in partnerships.

“Novo Nordisk is committed to working together with local authorities, investors and NGOs to build trust and confidence among patients, healthcare practitioners and policy makers,” says Sandeep Sur, general manager, Novo Nordisk Indonesia. “We must leverage all our joint capabilities and competences if we want to improve knowledge, treatment and better care.”

According to the analysis, improved awareness, accessibility, affordability and quality of care could reduce both diabetes-related complications and costs. Over the remaining lifetime of people with diabetes in Indonesia, more than 37,000 diabetes-related heart attacks and more than 400,000 diabetes-related kidney failures could be prevented, nearly 6 billion USD could be saved in diabetes treatment costs and more than 4.6 million life-years could be gained.

Click here for the complete issue.